No profile data available.
Orchestra BioMed Holdings, Inc. (OBIO) is a healthcare company in the heart treatment equipment industry, based in New Hope, United States, with about 86 full-time employees.
It reported revenue of $33.48 million for fiscal year 2025, up 1169.2% from fiscal year 2024, and net income of -$52.96 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $88,000, down 89.5% from a year before. Its market capitalization was $357.63 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States.
Orchestra BioMed reported $33.48 million in revenue for fiscal year 2025, up 1169.2% from $2.64 million in fiscal year 2024. In Q2 2026 revenue was $88,000.
$357.63 million as of October 9, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include AtriCure, Inc. (ATRC), Kestra Medical Technologies, Ltd. (KMTS), Anteris Technologies Global Corp. (AVR), Picard Medical, Inc. (PMI).